Derya Unutmaz, an immunologist at The Jackson Laboratory for Genomic Medicine, handed a three-year-old dataset to OpenAI's GPT-5 Pro-and got answers his team had been chasing since 2022.
The AI identified patterns in T cell gene expression across age groups, generating novel hypotheses that align with decades of prior research. Analysis that would have taken months of human labor was completed in minutes.
Unutmaz stresses that human oversight remains essential: the model generates hypotheses, but researchers must design experiments and validate findings.
The work has no connection to cryptocurrency or blockchain; its real market implications lie in biotech and pharmaceutical R&D, where AI has the potential to compress drug discovery timelines.